Scott Lonning
Publications by Year
Research Areas
TGF-β signaling in diseases, Cancer Cells and Metastasis, Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Cancer, Hypoxia, and Metabolism
Most-Cited Works
- → Protection from Obesity and Diabetes by Blockade of TGF-β/Smad3 Signaling(2011)700 cited
- → Tumor Evasion of the Immune System by Converting CD4+CD25− T Cells into CD4+CD25+ T Regulatory Cells: Role of Tumor-Derived TGF-β(2007)440 cited
- → Tyr Phosphorylation of PDP1 Toggles Recruitment between ACAT1 and SIRT3 to Regulate the Pyruvate Dehydrogenase Complex(2014)299 cited
- → Transforming Growth Factor β Subverts the Immune System into Directly Promoting Tumor Growth through Interleukin-17(2008)250 cited
- → TGFβ1 Inhibition Increases the Radiosensitivity of Breast Cancer CellsIn Vitroand Promotes Tumor Control by RadiationIn Vivo(2011)237 cited
- → Resistance of Glioblastoma-Initiating Cells to Radiation Mediated by the Tumor Microenvironment Can Be Abolished by Inhibiting Transforming Growth Factor-β(2012)237 cited
- → Key Roles for Transforming Growth Factor β in Melanocyte Stem Cell Maintenance(2010)229 cited
- → An Anti–Transforming Growth Factor β Antibody Suppresses Metastasis via Cooperative Effects on Multiple Cell Compartments(2008)226 cited
- → Transforming growth factor beta inhibition increases mortality and left ventricular dilatation after myocardial infarction(2008)201 cited
- → Targeting the Transforming Growth Factor-β pathway inhibits human basal-like breast cancer metastasis(2010)165 cited